Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 14 entries
Sorted by: Best Match Show Resources per page
Successful treatment of rhabdomyolysis and acute renal failure following amoxapine overdose.

International journal of psychiatry in clinical practice

Shigemura Tatsuro Kuwahara Soichiro Nomura Akimitsu Yokoyama Hideki Uemura J.
PMID: 24921698
Int J Psychiatry Clin Pract. 2001;5(4):287-90. doi: 10.1080/13651500152733071.

Amoxapine, a tricyclic antidepressant, is widely used by psychiatrists. While overdose of tricyclic antidepressants is known to be dangerous and potentially fatal (causing hypotension, arrhythmia, convulsions, respiratory failure, and other serious complications), overdose of amoxapine can cause other problems,...

Cite
Shigemura Tatsuro Kuwahara Soichiro Nomura Akimitsu Yokoyama Hideki Uemura J. Successful treatment of rhabdomyolysis and acute renal failure following amoxapine overdose. Int J Psychiatry Clin Pract. 2001;5(4):287-90doi: 10.1080/13651500152733071.
Shigemura Tatsuro Kuwahara Soichiro Nomura Akimitsu Yokoyama Hideki Uemura, J. (2001). Successful treatment of rhabdomyolysis and acute renal failure following amoxapine overdose. International journal of psychiatry in clinical practice, 5(4), 287-90. https://doi.org/10.1080/13651500152733071
Shigemura Tatsuro Kuwahara Soichiro Nomura Akimitsu Yokoyama Hideki Uemura, J. "Successful treatment of rhabdomyolysis and acute renal failure following amoxapine overdose." International journal of psychiatry in clinical practice vol. 5,4 (2001): 287-90. doi: https://doi.org/10.1080/13651500152733071
Shigemura Tatsuro Kuwahara Soichiro Nomura Akimitsu Yokoyama Hideki Uemura J. Successful treatment of rhabdomyolysis and acute renal failure following amoxapine overdose. Int J Psychiatry Clin Pract. 2001;5(4):287-90. doi: 10.1080/13651500152733071. PMID: 24921698.
Copy Download .nbib Format: NLM
Resensitization of methicillin-resistant .

Heliyon

Wilson TJ, Blackledge MS, Vigueira PA.
PMID: 29349359
Heliyon. 2018 Jan 12;4(1):e00501. doi: 10.1016/j.heliyon.2017.e00501. eCollection 2018 Jan.

The rapid increase in bacterial resistance to antibiotics is a global healthcare crisis. Non-antibiotic pharmaceuticals that have attained approval by the United States Food and Drug Administration have the potential to be repurposed as bacterial resistance-modifying agents and therefore...

Cite
Wilson TJ, Blackledge MS, Vigueira PA. Resensitization of methicillin-resistant . Heliyon. 2018;4(1):e00501doi: 10.1016/j.heliyon.2017.e00501.
Wilson, T. J., Blackledge, M. S., & Vigueira, P. A. (2018). Resensitization of methicillin-resistant . Heliyon, 4(1), e00501. https://doi.org/10.1016/j.heliyon.2017.e00501
Wilson, Tyler J, et al. "Resensitization of methicillin-resistant ." Heliyon vol. 4,1 (2018): e00501. doi: https://doi.org/10.1016/j.heliyon.2017.e00501
Wilson TJ, Blackledge MS, Vigueira PA. Resensitization of methicillin-resistant . Heliyon. 2018 Jan 12;4(1):e00501. doi: 10.1016/j.heliyon.2017.e00501. eCollection 2018 Jan. PMID: 29349359; PMCID: PMC5767979.
Copy Download .nbib Format: NLM
Amoxapine-induced tardive dyskinesia.

Indian journal of psychiatry

Singh GP.
PMID: 20048464
Indian J Psychiatry. 2009 Oct-Dec;51(4):327. doi: 10.4103/0019-5545.58305.

No abstract available.

Cite
Singh GP. Amoxapine-induced tardive dyskinesia. Indian J Psychiatry. 2009;51(4):327doi: 10.4103/0019-5545.58305.
Singh, G. P. (2009). Amoxapine-induced tardive dyskinesia. Indian journal of psychiatry, 51(4), 327. https://doi.org/10.4103/0019-5545.58305
Singh, Gurvinder Pal. "Amoxapine-induced tardive dyskinesia." Indian journal of psychiatry vol. 51,4 (2009): 327. doi: https://doi.org/10.4103/0019-5545.58305
Singh GP. Amoxapine-induced tardive dyskinesia. Indian J Psychiatry. 2009 Oct-Dec;51(4):327. doi: 10.4103/0019-5545.58305. PMID: 20048464; PMCID: PMC2802386.
Copy Download .nbib Format: NLM
Crystal structure of a mixed solvated form of amoxapine acetate.

Acta crystallographica. Section E, Crystallographic communications

Bhardwaj RM, Raval V, Oswald ID, Florence AJ.
PMID: 25878802
Acta Crystallogr E Crystallogr Commun. 2015 Jan 10;71:139-41. doi: 10.1107/S2056989014028096. eCollection 2015 Feb 01.

The mixed solvated salt 4-(2-chloro-dibenzo[b,f][1,4]oxazepin-11-yl)piperazin-1-ium acetate-acetic acid-cyclo-hexane (2/2/1), C17H17ClN3O(+)·C2H3O2 (-)·C2H4O2·0.5C6H12, crystallizes with one mol-ecule of protonated amoxapine (AXPN), an acetate anion and a mol-ecule of acetic acid together with half a mol-ecule of cyclo-hexane. In the centrosymmetric crystal, both...

Cite
Bhardwaj RM, Raval V, Oswald ID, et al. Crystal structure of a mixed solvated form of amoxapine acetate. Acta Crystallogr E Crystallogr Commun. 2015;71:139-41doi: 10.1107/S2056989014028096.
Bhardwaj, R. M., Raval, V., Oswald, I. D., & Florence, A. J. (2015). Crystal structure of a mixed solvated form of amoxapine acetate. Acta crystallographica. Section E, Crystallographic communications, 71139-41. https://doi.org/10.1107/S2056989014028096
Bhardwaj, Rajni M, et al. "Crystal structure of a mixed solvated form of amoxapine acetate." Acta crystallographica. Section E, Crystallographic communications vol. 71 (2015): 139-41. doi: https://doi.org/10.1107/S2056989014028096
Bhardwaj RM, Raval V, Oswald ID, Florence AJ. Crystal structure of a mixed solvated form of amoxapine acetate. Acta Crystallogr E Crystallogr Commun. 2015 Jan 10;71:139-41. doi: 10.1107/S2056989014028096. eCollection 2015 Feb 01. PMID: 25878802; PMCID: PMC4384552.
Copy Download .nbib Format: NLM
Identification and Functional Analysis of Long Non-coding RNAs in Autism Spectrum Disorders.

Frontiers in genetics

Tong Z, Zhou Y, Wang J.
PMID: 33193567
Front Genet. 2020 Sep 16;11:849. doi: 10.3389/fgene.2020.00849. eCollection 2020.

Genetic and environmental factors, alone or in combination, contribute to the pathogenesis of autism spectrum disorder (ASD). Although many protein-coding genes have now been identified as disease risk genes for ASD, a detailed illustration of long non-coding RNAs (lncRNAs)...

Cite
Tong Z, Zhou Y, Wang J. Identification and Functional Analysis of Long Non-coding RNAs in Autism Spectrum Disorders. Front Genet. 2020;11:849doi: 10.3389/fgene.2020.00849.
Tong, Z., Zhou, Y., & Wang, J. (2020). Identification and Functional Analysis of Long Non-coding RNAs in Autism Spectrum Disorders. Frontiers in genetics, 11849. https://doi.org/10.3389/fgene.2020.00849
Tong, Zhan, et al. "Identification and Functional Analysis of Long Non-coding RNAs in Autism Spectrum Disorders." Frontiers in genetics vol. 11 (2020): 849. doi: https://doi.org/10.3389/fgene.2020.00849
Tong Z, Zhou Y, Wang J. Identification and Functional Analysis of Long Non-coding RNAs in Autism Spectrum Disorders. Front Genet. 2020 Sep 16;11:849. doi: 10.3389/fgene.2020.00849. eCollection 2020. PMID: 33193567; PMCID: PMC7525012.
Copy Download .nbib Format: NLM
Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Fiscon G, Conte F, Amadio S, Volonté C, Paci P.
PMID: 33987813
Neurotherapeutics. 2021 Jul;18(3):1678-1691. doi: 10.1007/s13311-021-01064-z. Epub 2021 May 13.

The continuous adherence to the conventional "one target, one drug" paradigm has failed so far to provide effective therapeutic solutions for heterogeneous and multifactorial diseases as amyotrophic lateral sclerosis (ALS), a rare progressive and chronic, debilitating neurological disease for...

Cite
Fiscon G, Conte F, Amadio S, et al. Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis. Neurotherapeutics. 2021;18(3):1678-1691doi: 10.1007/s13311-021-01064-z.
Fiscon, G., Conte, F., Amadio, S., Volonté, C., & Paci, P. (2021). Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 18(3), 1678-1691. https://doi.org/10.1007/s13311-021-01064-z
Fiscon, Giulia, et al. "Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis." Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics vol. 18,3 (2021): 1678-1691. doi: https://doi.org/10.1007/s13311-021-01064-z
Fiscon G, Conte F, Amadio S, Volonté C, Paci P. Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis. Neurotherapeutics. 2021 Jul;18(3):1678-1691. doi: 10.1007/s13311-021-01064-z. Epub 2021 May 13. PMID: 33987813; PMCID: PMC8609089.
Copy Download .nbib Format: NLM
A possible mechanism of toxicity by the antidepressant amoxapine based on its effects in three in vitro models.

Toxicology in vitro : an international journal published in association with BIBRA

Ferguson LR, Cooper GJ, Loiselle DS, Roberton AM.
PMID: 20702294
Toxicol In Vitro. 1989;3(4):285-91. doi: 10.1016/0887-2333(89)90035-0.

When the antidepressant amoxapine is taken in overdose, it can cause metabolic acidosis, brain damage and sometimes death. In previous studies, biochemical evidence has been presented that amoxapine disrupts reactions of membrane-associated multi-enzyme complexes, and mitochondrial energy conservation may...

Cite
Ferguson LR, Cooper GJ, Loiselle DS, et al. A possible mechanism of toxicity by the antidepressant amoxapine based on its effects in three in vitro models. Toxicol In Vitro. 1989;3(4):285-91doi: 10.1016/0887-2333(89)90035-0.
Ferguson, L. R., Cooper, G. J., Loiselle, D. S., & Roberton, A. M. (1989). A possible mechanism of toxicity by the antidepressant amoxapine based on its effects in three in vitro models. Toxicology in vitro : an international journal published in association with BIBRA, 3(4), 285-91. https://doi.org/10.1016/0887-2333(89)90035-0
Ferguson, L R, et al. "A possible mechanism of toxicity by the antidepressant amoxapine based on its effects in three in vitro models." Toxicology in vitro : an international journal published in association with BIBRA vol. 3,4 (1989): 285-91. doi: https://doi.org/10.1016/0887-2333(89)90035-0
Ferguson LR, Cooper GJ, Loiselle DS, Roberton AM. A possible mechanism of toxicity by the antidepressant amoxapine based on its effects in three in vitro models. Toxicol In Vitro. 1989;3(4):285-91. doi: 10.1016/0887-2333(89)90035-0. PMID: 20702294.
Copy Download .nbib Format: NLM
The interaction of a benzodiazepine receptor antagonist (Ro15-1788) with GABA and GABA receptor antagonists at the GABA(A) receptor chloride-ionophore complex.

Neurochemistry international

Malatynska E, Dilsaver SC, Knapp RJ, Giroux ML, Ikeda M, Yamamura HI.
PMID: 20504718
Neurochem Int. 1991;18(3):405-10. doi: 10.1016/0197-0186(91)90173-b.

The effect of the GABA(A) receptor antagonists bicuculline and SR 95531 was compared with that of the antidepressants amoxapine and amitriptyline on GABA-stimulated (36)CL(?) uptake using membrane vesicles from the rat cerebral cortex. The interaction of Ro15-1788 with these...

Cite
Malatynska E, Dilsaver SC, Knapp RJ, et al. The interaction of a benzodiazepine receptor antagonist (Ro15-1788) with GABA and GABA receptor antagonists at the GABA(A) receptor chloride-ionophore complex. Neurochem Int. 1991;18(3):405-10doi: 10.1016/0197-0186(91)90173-b.
Malatynska, E., Dilsaver, S. C., Knapp, R. J., Giroux, M. L., Ikeda, M., & Yamamura, H. I. (1991). The interaction of a benzodiazepine receptor antagonist (Ro15-1788) with GABA and GABA receptor antagonists at the GABA(A) receptor chloride-ionophore complex. Neurochemistry international, 18(3), 405-10. https://doi.org/10.1016/0197-0186(91)90173-b
Malatynska, E, et al. "The interaction of a benzodiazepine receptor antagonist (Ro15-1788) with GABA and GABA receptor antagonists at the GABA(A) receptor chloride-ionophore complex." Neurochemistry international vol. 18,3 (1991): 405-10. doi: https://doi.org/10.1016/0197-0186(91)90173-b
Malatynska E, Dilsaver SC, Knapp RJ, Giroux ML, Ikeda M, Yamamura HI. The interaction of a benzodiazepine receptor antagonist (Ro15-1788) with GABA and GABA receptor antagonists at the GABA(A) receptor chloride-ionophore complex. Neurochem Int. 1991;18(3):405-10. doi: 10.1016/0197-0186(91)90173-b. PMID: 20504718.
Copy Download .nbib Format: NLM
Addition of amoxapine improves positive and negative symptoms in a patient with schizophrenia.

Therapeutic advances in psychopharmacology

Reeves KC, Virk S, Niedermier J, Duchemin AM.
PMID: 24294487
Ther Adv Psychopharmacol. 2013 Dec;3(6):340-2. doi: 10.1177/2045125313499363.

No abstract available.

Cite
Reeves KC, Virk S, Niedermier J, et al. Addition of amoxapine improves positive and negative symptoms in a patient with schizophrenia. Ther Adv Psychopharmacol. 2013;3(6):340-2doi: 10.1177/2045125313499363.
Reeves, K. C., Virk, S., Niedermier, J., & Duchemin, A. M. (2013). Addition of amoxapine improves positive and negative symptoms in a patient with schizophrenia. Therapeutic advances in psychopharmacology, 3(6), 340-2. https://doi.org/10.1177/2045125313499363
Reeves, Kevin C, et al. "Addition of amoxapine improves positive and negative symptoms in a patient with schizophrenia." Therapeutic advances in psychopharmacology vol. 3,6 (2013): 340-2. doi: https://doi.org/10.1177/2045125313499363
Reeves KC, Virk S, Niedermier J, Duchemin AM. Addition of amoxapine improves positive and negative symptoms in a patient with schizophrenia. Ther Adv Psychopharmacol. 2013 Dec;3(6):340-2. doi: 10.1177/2045125313499363. PMID: 24294487; PMCID: PMC3840811.
Copy Download .nbib Format: NLM
Phenelzine and Amoxapine Inhibit Tyramine and d-Glucuronic Acid Catabolism in Clinically Significant .

Pathogens (Basel, Switzerland)

Burin R, Shah DH.
PMID: 33924374
Pathogens. 2021 Apr 13;10(4). doi: 10.3390/pathogens10040469.

Non-typhoidal

Cite
Burin R, Shah DH. Phenelzine and Amoxapine Inhibit Tyramine and d-Glucuronic Acid Catabolism in Clinically Significant . Pathogens. 2021;10(4)doi: 10.3390/pathogens10040469.
Burin, R., & Shah, D. H. (2021). Phenelzine and Amoxapine Inhibit Tyramine and d-Glucuronic Acid Catabolism in Clinically Significant . Pathogens (Basel, Switzerland), 10(4), . https://doi.org/10.3390/pathogens10040469
Burin, Raquel, and Shah, Devendra H. "Phenelzine and Amoxapine Inhibit Tyramine and d-Glucuronic Acid Catabolism in Clinically Significant ." Pathogens (Basel, Switzerland) vol. 10,4 (2021). doi: https://doi.org/10.3390/pathogens10040469
Burin R, Shah DH. Phenelzine and Amoxapine Inhibit Tyramine and d-Glucuronic Acid Catabolism in Clinically Significant . Pathogens. 2021 Apr 13;10(4). doi: 10.3390/pathogens10040469. PMID: 33924374; PMCID: PMC8070173.
Copy Download .nbib Format: NLM
Antidepressants: which one?.

Canadian family physician Medecin de famille canadien

Remick RA.
PMID: 21267155
Can Fam Physician. 1986 Mar;32:587-92.

There are now 15 effective antidepressant medicines marketed in Canada (eight tricyclic antidepressants, three monoamine oxidase inhibitors, and four medicines with novel chemical structures). The tricyclics remain the drug of first choice for major depressions, because of their proven...

Cite
Remick RA. Antidepressants: which one?. Can Fam Physician. 1986;32:587-92
Remick, R. A. (1986). Antidepressants: which one?. Canadian family physician Medecin de famille canadien, 32587-92.
Remick, R A. "Antidepressants: which one?." Canadian family physician Medecin de famille canadien vol. 32 (1986): 587-92.
Remick RA. Antidepressants: which one?. Can Fam Physician. 1986 Mar;32:587-92. PMID: 21267155; PMCID: PMC2327679.
Copy Download .nbib Format: NLM
Salts of Amoxapine with Improved Solubility for Enhanced Pharmaceutical Applicability.

ACS omega

Joshi M, Roy Choudhury A.
PMID: 30023832
ACS Omega. 2018 Feb 28;3(2):2406-2416. doi: 10.1021/acsomega.7b02023. Epub 2018 Feb 27.

The objective of pharmaceutical cocrystallization is to create crystalline analogues that have vastly different properties, such as solubility, melting point, stability, and bioavailability from that observed in the pure active pharmaceutical ingredients (APIs). Amoxapine is a benzoxazepine derivative and...

Cite
Joshi M, Roy Choudhury A. Salts of Amoxapine with Improved Solubility for Enhanced Pharmaceutical Applicability. ACS Omega. 2018;3(2):2406-2416doi: 10.1021/acsomega.7b02023.
Joshi, M., & Roy Choudhury, A. (2018). Salts of Amoxapine with Improved Solubility for Enhanced Pharmaceutical Applicability. ACS omega, 3(2), 2406-2416. https://doi.org/10.1021/acsomega.7b02023
Joshi, Mayank, and Roy Choudhury, Angshuman. "Salts of Amoxapine with Improved Solubility for Enhanced Pharmaceutical Applicability." ACS omega vol. 3,2 (2018): 2406-2416. doi: https://doi.org/10.1021/acsomega.7b02023
Joshi M, Roy Choudhury A. Salts of Amoxapine with Improved Solubility for Enhanced Pharmaceutical Applicability. ACS Omega. 2018 Feb 28;3(2):2406-2416. doi: 10.1021/acsomega.7b02023. Epub 2018 Feb 27. PMID: 30023832; PMCID: PMC6045396.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 14 entries